Pamidronate treatment of hypercalcemia caused by vitamin D toxicity.

Pamidronate treatment of hypercalcemia caused by vitamin D toxicity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pamidronate treatment of hypercalcemia caused by vitamin D toxicity. Abstract Text:

Manjula Chatterjee,Phyllis W Speiser,Manjula Chatterjee,Phyllis W Speiser,

We present a 16 month-old previously healthy boy with refractory hypercalcemia due to an overdose of an over-the-counter vitamin supplement. The patient presented to the emergency department with a few weeks' history of irritability, constipation and intermittent vomiting. His serum calcium was found to be 18 mg/dl. He was first treated with intravenous fluids, furosemide and glucocorticoids without significant improvement, but became eucalcemic within 24 hours after receiving a single dose of pamidronate. This case highlights the potential danger of high dose vitamin supplements in children, and the salutary effects of treatment with bisphosphonate.

Pamidronate treatment of hypercalcemia caused by vitamin D toxicity. Publishing Authors By Initials

M Chatterjee,PW Speiser,M Chatterjee,PW Speiser,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pamidronate treatment of hypercalcemia caused by vitamin D toxicity. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of pediatric endocrinology & metabolism :

VOLUME: 20

Page Numbers: 1241-8

Journal Abbreviation: J. Pediatr. Endocrinol. Metab.

ISSN: 0334-018X

DAY: 10

MONTH: Nov

YEAR: 2007

Pamidronate treatment of hypercalcemia caused by vitamin D toxicity. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9508900

Pamidronate treatment of hypercalcemia caused by vitamin D toxicity. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pamidronate treatment of hypercalcemia caused by vitamin D toxicity. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pamidronate treatment of hypercalcemia caused by vitamin D toxicity.

AFFILIATION: Division of Pediatric Endocrinology, Schneider Children's Hospital, New Hyde Park, NY 11040, USA. Mchatter@nshs.edu

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Pediatr Endocrinol Metab

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pamidronate treatment of hypercalcemia caused by vitamin D toxicity Related Publications

• A Novel Population of Human Melanoma-Specific CD8 T Cells Recognizes Melan-AMART-1 Immunodominant Nonapeptide but Not the Corresponding Decapeptide.
• An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain.
• Another culture, another time.
• Four cases of granuloma inguinale of cervix diagnosed clinically as carcinoma.
• Growth hormone improves growth rate and preserves renal function in Dent disease.
• Interpretation of pediatric endocrine laboratory tests: pitfalls in steroid hormone measurements and genotyping.
• Pamidronate treatment of hypercalcemia caused by vitamin D toxicity.
• Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia.
• Serodiagnosis of tissue dwelling parasites: appalication of a multi-antigen enzyme-linked immunosorbent assay (ELISA) for screening.
• Understanding ultraviolet light.
• [A simplified method of determining the Rh factor.]
• [Ambulatory ophthalmologic surgery]
• [Diffuse intraacinous liver cirrhosis and congenital dropsy due to Rh-incompatibility.]
• [Hemostaseologic changes as causes of venous thromboses]
• [Not Available.]
• [Not Available.]
• [Ophthalmogenic headache]
• [Optic fundus and arterial hypertension (author's transl)]
• [Pharmaceutical aspects of drug side effects]
• [The indication for cataract extraction (author's transl)]